
Overlap Results

Collection(s):	C2, C7, H
# overlaps shown:	20
# genesets in collections:	9684
# genes in comparison (n):	49
# genes in universe (N):	45956

Gene Set Name	# Genes in Gene Set (K)	Description	# Genes in Overlap (k)	k/K	p-value	FDR q-value
GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	200	Genes up-regulated in effector CD8 T cells: CXCR1+ [GeneID=3577] versus CXCR1- [GeneID=3577].	14	0.0700	3.25E-22	3.15E-18
GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	175	Genes up-regulated in memory CD8 T cells: 1' versus 4'.	12	0.0686	5.17E-19	2.51E-15
GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	200	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	12	0.0600	2.65E-18	8.55E-15
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	107	Hepatic graft versus host disease (GVHD), day 7: up-regulated in allogeneic vs syngeneic bone marrow transplant.	10	0.0935	2.32E-17	5.61E-14
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	182	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 3 days after transduction.	11	0.0604	7.08E-17	1.37E-13
GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	199	Genes up-regulated in CD8 T cells during chronic infection with LCMV-Clone 13: effectors at day 6 versus exhausted at day 30.	11	0.0553	1.92E-16	1.78E-13
GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	200	Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 and then treated with Cl-IB-MECA [PubChem=3035850] versus stimulation by T cell membranes.	11	0.0550	2.03E-16	1.78E-13
GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	200	Genes up-regulated in HMC-1 (mast leukemia) cells incubated the peptide ALL1 versus those followed by treatment with Cl-IB-MECA [PubChem=3035850].	11	0.0550	2.03E-16	1.78E-13
GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	200	Genes up-regulated in T helper cells 5 days post polarization: Th1 versus Th17.	11	0.0550	2.03E-16	1.78E-13
GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	200	Genes up-regulated in CD8 T cells: KLRB1 int [GeneID=3820] versus KLRB1- [GeneID=3820].	11	0.0550	2.03E-16	1.78E-13
GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	200	Genes down-regulated in lymphoid primed multipotent progenitors: wildtype versus LYL1 [GeneID=4066] knockout.	11	0.0550	2.03E-16	1.78E-13
GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	167	Genes down-regulated in cells from Flt3L Melanom injected mice: splenic DEC205+ dendritic cells versus CD8 T cells.	10	0.0599	2.22E-15	1.79E-12
RODWELL_AGING_KIDNEY_UP	487	Genes whose expression increases with age in normal kidney.	13	0.0267	3.36E-15	2.51E-12
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	199	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	10	0.0503	1.31E-14	5.56E-12
GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	199	Genes up-regulated in HMC-1 (mast leukemia) cells: incubated with the peptide ALL1 versus stimulated with T cell membranes.	10	0.0503	1.31E-14	5.56E-12
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	199	Genes up-regulated in B lymphocytes: naïve versus plasmablasts.	10	0.0503	1.31E-14	5.56E-12
GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	200	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	10	0.0500	1.38E-14	5.56E-12
GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	200	Genes down-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	10	0.0500	1.38E-14	5.56E-12
GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	200	Genes up-regulated in KLRG1- SELL low [GeneID=10219;6402] T reg: CD69- [GeneID=969] versus CD69+ [GeneID=969].	10	0.0500	1.38E-14	5.56E-12
GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP	200	Genes up-regulated in CD8 T cells 6 days after immunization: control versus IL2 [GeneID=3558] treatment.	10	0.0500	1.38E-14	5.56E-12


Gene/Gene Set Overlap Matrix

Entrez Gene Id	Gene Symbol	Gene Description	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
6772	STAT1	signal transducer and activator of transcription 1, 91kDa	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN		GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
3665	IRF7	interferon regulatory factor 7	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN		GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN		GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
3434	IFIT1	interferon-induced protein with tetratricopeptide repeats 1	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP				GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN		
3959	LGALS3BP	lectin, galactoside-binding, soluble, 3 binding protein	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP			GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN		GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN		GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
57674	RNF213	ring finger protein 213	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN		TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP		GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP		GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP			GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN		
219285	SAMD9L	sterile alpha motif domain containing 9-like	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN		TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP		GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP			RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN		
25939	SAMHD1	SAM domain and HD domain 1	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP		ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP			GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	RODWELL_AGING_KIDNEY_UP		GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP				GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
51246	SHISA5	shisa homolog 5 (Xenopus laevis)	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP		GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP				GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP					RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP				
54625	PARP14	poly (ADP-ribose) polymerase family, member 14	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP		GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN		TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN	RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
151636	DTX3L	deltex 3-like (Drosophila)	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP		GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN		TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP			RODWELL_AGING_KIDNEY_UP	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN		
94240	EPSTI1	epithelial stromal interaction 1 (breast)	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP		GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN		TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP		GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP		GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN		GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN		GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
2634	GBP2	guanylate binding protein 2, interferon-inducible	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP			ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP		GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN			GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP				GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
8821	INPP4B	inositol polyphosphate-4-phosphatase, type II, 105kDa	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP				TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP															
221178	SPATA13	spermatogenesis associated 13	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP					GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP														
23646	PLD3	phospholipase D family, member 3		GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP		ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP																
6281	S100A10	S100 calcium binding protein A10		GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP			TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP															
3958	LGALS3	lectin, galactoside-binding, soluble, 3		GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP										GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN								GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
1396	CRIP1	cysteine-rich protein 1 (intestinal)		GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP											RODWELL_AGING_KIDNEY_UP							GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
79026	AHNAK	AHNAK nucleoprotein		GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP																		GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
115361	GBP4	guanylate binding protein 4			GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP		GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP			GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN			GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN		GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
6672	SP100	SP100 nuclear antigen			GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN														GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN		
8809	IL18R1	interleukin 18 receptor 1				ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP							GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN									GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
10123	ARL4C	ADP-ribosylation factor-like 4C						GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP							RODWELL_AGING_KIDNEY_UP							
23528	ZNF281	zinc finger protein 281											GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN								GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
79071	ELOVL6	ELOVL fatty acid elongase 6											GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN								GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	
115330	GPR146	G protein-coupled receptor 146											GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN									
7431	VIM	vimentin													RODWELL_AGING_KIDNEY_UP							GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
2533	FYB	FYN binding protein													RODWELL_AGING_KIDNEY_UP							
4050	LTB	lymphotoxin beta (TNF superfamily, member 3)													RODWELL_AGING_KIDNEY_UP							
57580	PREX1	phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1													RODWELL_AGING_KIDNEY_UP							
7805	LAPTM5	lysosomal protein transmembrane 5													RODWELL_AGING_KIDNEY_UP							
3956	LGALS1	lectin, galactoside-binding, soluble, 1																				GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
79895	ATP8B4	ATPase, class I, type 8B, member 4																				GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
3690	ITGB3	integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)																				GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP
6653	SORL1	sortilin-related receptor, L(DLR class) A repeats containing																				
22821	RASA3	RAS p21 protein activator 3																				
149628	PYHIN1	pyrin and HIN domain family, member 1																				
23406	COTL1	coactosin-like 1 (Dictyostelium)																				
3575	IL7R	interleukin 7 receptor																				
54	ACP5	acid phosphatase 5, tartrate resistant																				
133418	EMB	embigin																				
25851	TECPR1	tectonin beta-propeller repeat containing 1																				
28951	TRIB2	tribbles homolog 2 (Drosophila)																				
3460	IFNGR2	interferon gamma receptor 2 (interferon gamma transducer 1)																				
2908	NR3C1	nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)																				
54440	SASH3	SAM and SH3 domain containing 3																				
8694	DGAT1	diacylglycerol O-acyltransferase 1																				
57326	PBXIP1	pre-B-cell leukemia homeobox interacting protein 1																				
27250	PDCD4	programmed cell death 4 (neoplastic transformation inhibitor)																				
